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Abstract
The amidated analog of Plantaricin149, an antimicrobial peptide from Lactobacillus plantarum
NRIC 149, directly interacts with negatively charged liposomes and bacterial membranes, leading to
their lysis. In this study, four Pln149-analogs were synthesized with different hydrophobic groups at
their N-terminus with the goal of evaluating the effect of the modifications at this region in the pep-
tide’s antimicrobial properties. The interaction of these peptides with membrane models, surface ac-
tivity, their hemolytic effect on red blood cells, and antibacterial activity against microorganisms
were evaluated. The analogs presented similar action of Plantaricin149a; three of them with no
hemolytic effect (< 5%) until 0.5 mM, in addition to the induction of a helical element when binding
to negative liposomes. The N-terminus difference between the analogs and Plantaricin149a retained
the antibacterial effect on S. aureus and P. aeruginosa for all peptides (MIC50 of 19 M and 155 M
to Plantaricin149a, respectively) but resulted in a different mechanism of action against the microor-
ganisms, that was bactericidal for Plantaricin149a and bacteriostatic for the analogs. This difference
was confirmed by a reduction in leakage action for the analogs. The lytic activity of Plantaricin149a
is suggested to be a result of the peptide-lipid interactions from the amphipathic helix and the hydro-
phobic residues at the N-terminus of the antimicrobial peptide.
Key words: antimicrobial activity; antimicrobial peptide; calcein leakage, hemolytic assay.
Introduction
It is increasingly common to find strains of pathogens
which are antibiotic resistant, and some of them are resis-
tant to many antibiotics and chemotherapeutic agents (Ni-
kaido, 2009). This phenomenon of multidrug resistance in
bacteria has led to the development of new antibiotics, to
the modification of the existing drugs, and to the use of two
or more of the available antibiotics in association to deal
with the resistant strains (Toke, 2005; Nikaido, 2009).
As an alternative to this process (Marshall and Are-
nas, 2003), antimicrobial peptides (AMPs) represent a pro-
mising class of compounds that were shown to maximize
their inhibitory activity against pathogenic microorganisms
by the manipulation of this chemical structure, since it is
possible to introduce different modifications on their pri-
mary structure, like amidation, cyclation and insertion of
non-proteic groups on their N-terminal end (Boman, 1995;
Tsuberya et al., 2001; Gordon and Romanowski, 2005;
Gong et al., 2011).
Lactic acid bacteria (LAB) are currently exploited as
a reservoir of AMPs which present potential technological
applications (McKay and Baldwin, 1990; Zavisic et al.,
2012). Plantaricin 149 (Pln149, YSLQMGATAIKQVKK
LFKKKGG) is a naturally occurring 22-amino acid pep-
tide, isolated from Lactobacillus plantarum NRIC149
(Kato et al., 1994). Its synthetic amidated analog, Pln149a,
is a positively charged linear peptide with a narrow spec-
trum towards Staphylococcus aureus and Listeria mono-
cytogenes that undergoes a typical helical induction in a
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non-polar environment or when it interacts with negative
biomembranes (Muller et al., 2007). The action of Pln149a
against Saccharomyces cerevisae was also established,
showing the peptide causes morphological changes on the
yeast cell, due to its interaction with the membrane, fol-
lowed by its disruption (Lopes et al., 2009).
The mechanism of action proposed for Pln149a is an
electrostatic attraction of the disordered peptide in the bulk
solution to the charged phospholipids in the membrane that
induces an amphipathic -helix in the peptide structure and
its accumulation on the phospholipid surface. The amphi-
pathic helix stretches from residue Ala7 to Lys20, creating a
polar side with 5 Lys residues that enables interactions, and a
non-polar side, due to its hydrophobic residues (Ala, Leu,
Ile, Phe, Val) that lead the Van de Waals contributions. At
this stage, it was suggested that the peptide must remain as-
sociated with the negatively phospholipids, and its N- termi-
nal residues are introduced in the phospholipids acyl chains,
gradually altering the surface packing of the lipid layer and
resulting in the membrane disruption (Lopes et al., 2009).
According to this mechanism, it can be proposed that
the positive region of Pln149a itself is likely to trigger its
antibacterial activity, since the helix stabilization repre-
sents a fundamental/essential step for the peptide-mem-
brane binding. In addition, it was demonstrated for the
antimicrobial peptide PlantaricinA (Kristiansen et al.,
2005) that the pentapeptide YSLQM, the same from the
N-terminus sequence of Pln149a, does not present signifi-
cant antibacterial properties. However, the assumption that
the N-terminus of Pln149a must be located in a non-polar
environment in the bacterial membrane suggests its partici-
pation in the peptide’s antimicrobial property.
In the present work, to study this assumption, four
other Pln149a analogs were synthesized; their antimi-
crobial and hemolytic activities and the interactions with
biomembrane models were investigated. The four analogs
retained the inhibitory activity against Pseudomonas
aeruginosa and Staphylococcus aureus growth but with a
different mechanism of action presented for Pln149a, sug-
gesting the importance of the N-terminus in the lytic prop-
erty of the antimicrobial peptide.
Materials and Methods
Materials
Chemicals were purchased from Sigma-Aldrich (St.
Louis, USA), unless stated. All protected amino acids, cou-
pling reagents and polymers were obtained from
NovaBiochem (San Diego, USA). Solvents were of P.A.
grade and buffers were prepared in MilliQ water and fil-
tered in 0.2 m polycarbonate membranes.
Peptide synthesis and purification
Pln149a was synthesized by the Fmoc strategy and
purified by Reverse Phase Chromatography as described
elsewhere (Lopes et al., 2009). The four new Pln149a
analogs were synthesized with the peptide size reduced by
the removal of the first 5 N-terminus residues of the
Pln149a primary structure, resulting in residue 6 to 22 of
Pln149a. In addition to this 17-amino acid peptide, three
different N-terminus modifications were introduced on the
synthetic analogs: a short hydrocarbon chain (acetyl
group), that was coupled an the N-terminus by the addition
of acetic anhydride 20% in DMF (dimethylformamide) for
5 min in the peptidyl-resin, followed by 100 L DIEA
(diisopropylethylamine) for 30 min incubation; a longer
hydrocarbon chain (N-octyl group), that was added by mix-
ing octanoic acid in DMF (1:1), followed by the addition of
DIEA, HOBt (Hydroxybenzotriazole) and PyBOP (benzo-
triazol-1-yl-oxytripyrrolidinophosphonium
hexafluorophosphate) according to the resin capacity, for 2
hours of incubation; and the Fmoc group of the last amino
acid residue coupled, that was retained at the peptide N-ter-
minus.
After the incorporation of all amino acid residues and
modifications, the peptides were cleaved with a mixture of
trifluoroacetic acid (TFA): triisopropylsilane (TIS): H2O
(95: 2.5:2.5, v/v) for 3 h. The crude peptides were precipi-
tated with cold diethyl ether, centrifuged at 700 g for 5 min
and lyophilized. The four Pln149-analogs were named as
Pln149(6-22), for the 17-amino acid peptide; Ac-
Pln149(6-22), for the acetylated analog; Noctyl-Pln149(6-
22), and Fmoc-Pln149(6-22).
Aliquots of each analog peptide were purified by re-
verse-phase chromatography using a GE ÄKTA Purifier
System (GE Healthcare) with an YMC-Pack Polymer C18
column (250 x 4.6 mm, 6 m bead size, Waters, Germany)
equilibrated with 0.1% (v/v) TFA/water (solvent A). Elu-
tion was performed at a 1 mL/min flow rate using a two-
step gradient: initially, from 0% to 70% solvent B (aceto-
nitrile 90% in water containing 0.1% TFA) over 40 min,
followed by 70-100% of the same solvent over 1 min.
Absorbance was monitored at 220 nm and the fractions of
each peptide were collected and lyophilized.
Peptide characterization
Mass Spectrometry analyses of Pln149a and all the
modified-analogs were performed with electrospray ion-
ization with a Quattro II electrospray triple quadrupole
spectrometer (Micromass, Manchester, UK) on positive
mode. Aliquots of each peptide (0.02 mg/mL) were pre-
pared in a mixture of 60/0.5/39.5 of methanol/formic
acid/water as the mobile flow phase, and further directly in-
jected in the spectrometer with a 10 L loop. Experiments
were performed by scanning from a 1000 to 2000 m/z ratio.
To check the primary structure of the purified
Pln149(6-22), automated Edman degradation was per-
formed on an automatic protein sequencer PPSQ-23A
Shimadzu (Kyoto, Japan).
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Circular dichroism (CD) analysis
The CD spectra of Pln149a and analog peptides were
recorded on a Jasco J-815 CD spectrometer (Tokyo, Japan)
from 190 to 250 nm, using a 0.1 cm path length rectangular
quartz cuvette, at 25 °C. For each spectrum, the data from 8
scans were averaged and the reference spectrum was sub-
tracted. Peptides were measured (0.15 mg/mL) in water and
in the presence of 1 mM of large unilamellar vesicles
(LUVs) of palmitoyl-oleoyl phosphatidyl glycerol
(POPG), a negatively charged vesicle, and of palmitoyl-
oleoyl phosphatidyl choline (POPC), a zwitterionic phos-
pholipid vesicle, prepared as described elsewhere (Lopes et
al., 2009).
Hemolytic activity against human erythrocytes
The present method was based on Castro et al.
(2009). Briefly, aliquots (100L) of 1% (v/v) suspension
human erythrocytes in 20 mM Sodium Phosphate buffer
(pH 7.4) containing 150 mM NaCl were employed to deter-
mine the hemolytic effect of Pln149a and analog peptides
in serial dilutions (1 to 500 M). Samples were incubated
for 1 h at 37 °C, centrifuged at 3000 g. The supernatant was
transferred to a 96-well microplate and evaluated spectro-
photometrically at 405 nm to monitor the release of hemo-
globin. Triton X-100 was used as control of 100% lysis, and
hemolysis percentage was calculated using the Eq. (1):
 
 
%hemolisis
Peptide PBS
Triton PBS
A A
A A



(1)
Antimicrobial activity and MIC determination
To study antibacterial activity of Pln149a and
analogs, microtiter broth growth inhibition assays were
conducted with the reference strains of Staphylococcus
aureus ATCC 25923 and Pseudomonas aeruginosa ATCC
9027, based on the method described elsewhere (Wayne,
1999), with some modifications.
The bacteria were firstly grown in Mueller-Hinton
broth (5 mL) at 37 °C. When OD600nm reached 1.0, the bac-
terial suspension was diluted in fresh Mueller-Hinton broth
and adjusted to OD600nm 0.010 (10
6 UFC/mL). Growth inhi-
bition assays were carried out by adding sterile Pln149a
(100 L) and each of the four derived peptides in PBS (pH
7.4) to a 96-well microtiter plate. Serial dilutions of the
peptides (620 to 1.2 M) were incubated with the diluted
bacterial suspension 1:1 (v/v) in Mueller-Hinton broth. A
positive control was used to incubate the bacterial suspen-
sion with PBS and a negative control containing 0.4% (v/v)
formaldehyde. Each microplate was incubated for 24 h, at
37 °C and growth inhibition was analyzed at 600 nm on a
Microplate TP-reader (Thermoplate). Minimal inhibitory
concentration (MIC50) was considered the lowest concen-
tration that inhibits 50% bacterial growth. All experiments
were performed in duplicate.
Additionally, to verify if the peptides action was ei-
ther bactericidal or bacteriostactic, aliquots (5 L) of each
well from the microplate were subcultived in a Petri plate
with Mueller-Hinton agar. The plates were incubated at
37 °C for 24 h and growth was visually detected.
The same assay was conducted with the Pln149-
peptides to study their antifungal activity against Candida
albicans, using the Brain Heart Infusion (BHI) medium.
Calcein leakage
To study the action of peptides to promote the calcein
leakage from the vesicles internal compartment, LUVs of
POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-
glycerol) with entrapped calcein were prepared by hydrat-
ing a dried lipid film with 35 mM calcein in Hepes 10 mM
buffer (pH 7.4), followed by a 10 freeze-thaw cycles and
extrusion through a 100 nm membrane. Untrapped calcein
was separated from the LUVs by size exclusion chromatog-
raphy on a Sephadex-G65 column, and liposomes concen-
tration was determined by McClare assays (McClare,
1971). The release of calcein from the LUVs was moni-
tored by adding increasing concentrations of each Pln149
analog peptide (0.25 to 4.0 M) to LUVs (0.1 mM) in a
quartz rectangular cuvette under agitation. Fluorescence
was measured at 520 nm on an ISS K2 spectrofluorimeter
(ISS Fluorescence, Analytical and Biomedical Instru-
ments) with excitation at 490 nm for 15 min incubation at
25º C. The percent leakage was determined according to the
Eq. (2):
 
 
%
max
Leakage
F F
F F




0
0
100 (2)
where the maximum fluorescence intensity (Fmax) was de-
termined by adding a solution of 10% (w/v) Triton X-100 to
the cuvette, F0 represents the initial fluorescence intensity
of the intact vesicle, and F, the intensity after 15 min incu-
bation with each peptide.
Results
Peptide synthesis, purification and characterization
Pln149a and other four analog peptides were synthe-
sized by solid phase method using the Fmoc chemistry. A
manual synthesis was successfully performed to yield a
peptide corresponding to Pln149a from residue 6 to 22. At
this step, the peptidyl-resin was equally subdivided in four
parts to generate each Pln149 reduced analog. The first one
was cleaved from the resin with no N-terminus insertions,
resulting in the analog Pln149(6-22). Three different
groups were attached to the N-terminal residue of pep-
tidyl-resin: an acetyl, an N-octyl, and a hydrophobic moiety
Fmoc, resulting in the three Pln149 analogs with N-ter-
minus modifications: Ac-Pln149(6-22), Noctyl-Pln149(6-
22) and Fmoc-Pln149(6-22), respectively. The primary
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structure (checked by Edman degradation), and molecular
weight (determined by electrospray mass spectrometry) of
each analog are in Table 1.
The four modified peptides were purified to homoge-
neity (> 98%) by HPLC. The purification chromatogram
profile, showed in Figure 1, revealed the efficiency of man-
ual synthesis due to the major peak of each analog and the
increase in hydrophobicity in the peptides, in which the an-
alog Pln149(6-22) was eluted at 32% of acetonitrile, and
the other-analogs containing the acetyl, the N-octyl and the
Fmoc groups were eluted at positions corresponding to a
43, 55, and 59% of acetonitrile, respectively.
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Table 1 - Primary structure, molecular weight, MIC and Minimum bactericidal concentration (MBC) of Pln149a and analogs.
S. aureus P. aeruginosa
Peptide Sequence MW (Da)* MIC MIC50 MBC MIC MIC50 MBC
Pln149a YSLQMGATAIKQVKKLFKKKGG 2423.7 78 19 78 310 155 310
Pln149(6-22) GATAIKQVKKLFKKKGG 1801.3 310 78 > 620 310 155 > 620
Ac-Pln149(6-22) Acetyl-GATAIKQVKKLFKKKGG 1843.3 310 78 > 620 310 155 > 620
Noctyl-Pln149(6-22) N-octyl-GATAIKQVKKLFKKKGG 1928.5 10 10 310 620 155 > 620
Fmoc-Pln149(6-22) Fmoc-GATAIKQVKKLFKKKGG 2023.5 38 38 155 78 19 155
Values are given in M.
*MW, molecular weight determined by mass spectrometry.
Figure 1 - Reverse-Phase Chromatography profile of Pln149a analog peptides. (A) Pln149(6-22), (B) Ac-Pln149(6-22), (C) Noctyl-Pln149(6-22),
(D) Fmoc-Pln149(6-22) on C18 column correspond to the major peak. Column was equilibrated with H2O (TFA 0.1%) and eluted in a gradient of
acetonitrile 90% (TFA 0.1%) over 40 min (dotted curves), in a 1 mL/min flow rate. The difference in hydrophobicity is a result of the peptide size reduc-
tion and the N-terminal modifications.
Circular dichroism (CD) studies
The CD spectra of all the analogs peptides in water
were similar to the Pln149a CD spectrum (9) and to the lin-
ear antimicrobial peptides in aqueous solution (Tsuberya et
al., 2001; Koo et al., 2008; Leite et al., 2008; Castro et al.,
2009), as showed in Figure 2A. These spectra are typical of
disordered secondary structure in a polypeptide chain, with
minima centered at 198 nm region.
The CD spectrum of each peptide was not altered
when in the presence of the zwitterionic vesicles of POPC
(data not shown). However, a significant conformational
change in the presence of the negatively charged vesicles
(POPG) was observed (Figure 2B), with the induction of a
helical element on its secondary structure, with minima at
222 and 208 nm and a maximum centered at 196 nm (Lopes
et al., 2009). This behavior is observed for cationic linear
helical antimicrobial peptides when in the presence of neg-
ative biomembrane models (Yeaman and Yount, 2003;
Sato and Feix, 2006; Zhao et al., 2006).
Hemolytic assay
In this assay, hemolysis was visually detected in posi-
tive control right after the addition of 1% (v/v) Triton
X-100, and sedimentation was observed for the negative
control (PBS). Cell sedimentation was observed for the
wells corresponding to Pln149 analogs in the range from 1
to 500 M, indicating no hemolytic activity (less than 5%)
for Pln149(6-22), Ac-Pln149(6-22), and Noctyl-Pln149(6-
22), data not shown. The analog Fmoc-Pln149(6-22) pre-
sented different behavior: weak hemolytic activity was ob-
served at concentrations below 125 M, however, at 250
and 500 M, a red solution was observed, indicating 12 and
24% hemolysis, respectively.
Antimicrobial assay
The antibacterial activity of Pln149a and the four
N-terminus modified peptides were directly assessed
against Staphylococcus aureus ATCC 25923, and Pseudo-
monas aeruginosa ATCC 9027. The MIC and MBC (mini-
mum bactericidal concentration) values are presented for
each peptide for each microorganism in Table 1.
Pln149a showed stronger antimicrobial activities
against Staphylococcus aureus. No bacterial growth was
observed in the presence of Pln149a from 78 to 620 M.
The inhibitory concentrations in which no bacterial growth
observed for P. aeruginosa were higher than 310 M.
Pln149a was proved to be lethal for these two microorgan-
isms, none of the aliquots in which inhibition was noted
from assay with both strains were capable of resuming
growth on agar plates in medium in the absence of Pln149a
after 24 h incubation due to its bactericidal action. How-
ever, the analogs (except the Fmoc-analog) presented a dif-
ferent mode of action, promoting a bacteriostatic inhibition
against S. aureus and P. aeruginosa in most of the wells in
which growth inhibition was detected.
The Fmoc-analog peptide presented a bactericide ac-
tivity in the wells with the most elevated concentrations of
the peptide (620 to 155 M) for both Staphylococcus
aureus and P. aeruginosa.
No growth inhibition was detected against Candida
albicans due to the action of Pln149a and analogs.
Leakage assays
The effects of vesicle perturbation by the presence of
each antimicrobial peptide analog to Pln149 were deter-
mined by calcein leakage experiments on POPG vesicles.
Pln149a and all the four analog peptides showed the capa-
bility of promoting the total leakage of calcein from the
liposomes. According to Figure 3, the percent of calcein re-
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Figure 2 - Far-UV CD spectra of Pln149a analog peptides. (A) Pln149a
(0.1 mg/mL) and the four analogs in aqueous solution. (B) Pln149a and
modified analogs in the presence of 1 mM DPPG vesicles. Measurements
were taken from 190 to 250 nm as the average of 8 scans, at 25 °C and us-
ing a 0.1 cm pathlength quartz cuvette.
Figure 3 - Leakage action of Pln149a and the four analogs peptides on
membrane models. Calcein leakage was promoted by the addition of in-
creasing concentrations of the peptides (0.25 to 4 M) to LUVs of POPG.
100% leakage occurred with the addition of Triton X-100.
leased from the vesicles increased proportionally to the
amount of peptide used in the assay, reaching approxi-
mately 100% leakage to the lowest lipid/peptide ratio in
cuvette to each analog.
Comparing the curves, once again the Fmoc-analog
presented a more accentuated action than the other analogs,
which is due to the introduction of the Fmoc moiety in the
liposomes acyl chains. However, observing the curves to
the other peptides, it was possible to note a higher leakage
action of Pln149a compared to the Pln149(6-22) and the
other two analogs with the removal of the 5 N-terminus res-
idues. The reduction in leakage action reveals the participa-
tion of this segment in the lytic action of Pln149a on the
membrane disruption.
Discussion
The analogs Ac-Pln149(6-22), Noctyl-Pln149(6-22),
and Fmoc-Pln149(6-22) presented an increase in hydro-
phobicity compared to Pln149(6-22), that is due to the
non-polar character in their N-terminus. Despite the in-
crease of non-polarity, three of these N-terminus modified
peptides remained with low level of hemolytic activity. The
weak hemolytic effect of Pln149a and analogs in front of
the red cell membranes is in agreement with the lack of
specificity/binding of Pln149a to zwitterionic phospho-
lipids vesicles. Only the Fmoc-Pln149(6-22) analog pre-
sented a more significant hemolytic property in concentra-
tions higher than 250 M. Zwitterionic phospholipids,
specially the ones from phosphatidylethanolamine series
(PE), are also the major component (approximately 89%)
of the Candida cellular membrane (Blondelle et al., 1999),
in which no growth inhibition was detected to the action of
the Plantaricin149 analogs.
Taking in account the two analogs Pln149a and
Pln149(6-22), in which the difference is due to the 5 first
N-terminus residues on the former, it can be noted an in-
crease in the MIC to the Staphylococcus aureus due to the
pentapeptide removal, this reduction in antimicrobial activ-
ity is in agreement with the decrease in leakage assays ob-
served for Pln149(6-22), that reveals a role for this region
of the antimicrobial peptide in its antibacterial activity. The
typical conformational change from random structure to
helical element, observed in CD studies for these two
analogs, revealed that the steps of electrostatic attraction
and the helix stabilization in the antimicrobial peptide bind-
ing to the liposomes does still remain on these peptides.
However, the reduction of Pln149a size resulted in a
slightly less appropriated molecule to interact with the
liposomes, reducing the magnitude of the helical content
induced on the binding, because the presence of the N-ter-
minus pentapeptide (YSLQM) to be in the target membrane
must favor the interactions of the amphipathic helix formed
in Pln149a.
Considering the modifications introduced on the pep-
tides end, they have neither caused severe perturbations on
the peptide structure, nor hindered the interaction of these
peptides with negative biomembranes, however no increa-
se in the peptide antimicrobial activity was observed for the
analogs in which an acetyl or N-octyl were attached at the
N-terminus. In Noctyl-Pln149(6-22), despite of the increa-
se of the hydrophobic of the peptide due to the attachment
of the acyl chain at the N-terminal end, the effect of disturb-
ing the integrity of both the phospholipid vesicles and the
bacterial and/or erythrocyte membranes was not signifi-
cantly changed. For Noctyl-Pln149(6-22), the incorpora-
tion of the acyl chain into the membranes did not severely
changed the phospholipid packing which could promote
the rupture of the membrane more effectively of that ob-
served to Pln149(6-22), the analog lacking the lipid modifi-
cation. Indeed, the use of fat acids to promote the lipidation
as a general method for increasing the peptide membrane-
perturbing activity has been questionable (Gatto et al.,
2006), since the final effect of the modified peptide tend to
be balanced between two opposite effects: the increase of
the affinity for the membrane phase, but at the same time, it
also makes favourable the peptide aggregation in water, re-
ducing the effective monomer concentration. This inability
of the acyl-analog peptides to alter the Pln149 antimi-
crobial activity indicates that a hydrocarbon chain can not
completely fulfill the requirements for the interaction of the
peptide with the membrane, suggesting that the hydropho-
bic environment of the biomembrane inner, created by the
phospholipids acyl chains, is not the most appropriated en-
vironment to accommodate this region of Pln149a, but this
instead the N-terminus pentapeptide must be located at the
lipid interface of the bacterial membrane, a region that
shares hydrophilic and hydrophobic features.
Conversely, in the analog with the 9-fluorenyl-
methyloxycarbonyl (Fmoc) moiety modification at the
N-terminal end, the disturbing effect of the peptide on bio-
logic membranes was remarkably enhanced. Differently
from the other Plantaricin149-analogs, the Fmoc version
did not required a negative density of charge to incorporate
on the membrane, as observed by its hemolytic properties
in concentrations above 125 M. In the absence of an elec-
trostatic interaction to attract the peptide to the membrane
surface, the high partition coefficient of the fluorene group,
which is used as a fluorescent probe in several membrane
studies (Azzi, 1975), has driven the binding to the mem-
brane, promoting the incorporation of the hydrophobic
Fmoc moiety among the phospholipid layers and signifi-
cantly altering the integrity of the lipids layers. The Fmoc-
analogue promoted a significant decrease in the MIC espe-
cially to the Gram-negative bacteria, which present a major
composition of lipopolysaccharides in the external mem-
brane and lipids of zwitterionic character.
Pln149a antimicrobial activity showed to be more ef-
fective against Gram-positive bacteria, a feature that is
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shared with many amphibian antimicrobial peptides (Tagg
et al., 1976) that present lowest MIC values to Staphylococ-
cus, Listeria. The difference in the bactericide/bacte-
riostatic mechanism of action of Pln149a and Pln149(6-22)
can be attributed to the removal of the N-terminus residues
in the latter, because this region must play a secondary role
in the peptide adsorption on the liposomes. Besides, the
other analogs (except the Fmoc-analog) presented higher
MICs values than Pln149a, confirming the importance of
the contribution from the N-terminus segment to Pln149
lytic activity at biologic membranes.
Interestingly, the Fmoc-Pln149(6-22) were more ac-
tive against Pseudomonas aeruginosa growth and, al-
though the reduction of the peptide size, the presence of this
highly hydrophobic group at this position conferred to the
analog a higher inhibitory property against this bacteria.
Additional findings could be included in the proposed
model for the Pln149a mechanism of action (Lpes et al.,
2009). Reducing the non-polar character of Pln149a, by the
removal of the first 5 N-terminus residues, does not annul
its antimicrobial property, given that some steps of the
binding to the negative liposome were still retained (the
electrostatic attraction, the induction of the amphipathic he-
lix and the adsorption of the helical element between the
phospholipid polar heads). The occurrence of these steps
resulted in a growth delay for the two bacteria tested. None-
theless, the absence of a peptide region to be introduced in
the lipid-aqueous interface can remove the lethal action of
this peptide.
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